This trial will help researchers understand how obesity affects the amount of oxalate excreted in urine, which could lead to new ways to prevent calcium oxalate stones from forming.
1 Primary · 0 Secondary · Reporting Duration: Baseline through Day 12
Active Control
40 Total Participants · 6 Treatment Groups
Primary Treatment: 45-50 BMI · No Placebo Group · N/A
Age 18 - 60 · All Participants · 2 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: